Financhill
Buy
64

BIXT Quote, Financials, Valuation and Earnings

Last price:
$0.1500
Seasonality move :
54.58%
Day range:
$0.1520 - $0.1745
52-week range:
$0.0615 - $0.2060
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
118.95x
P/B ratio:
--
Volume:
247.5K
Avg. volume:
316.4K
1-year change:
50.63%
Market cap:
$14.8M
Revenue:
--
EPS (TTM):
-$0.01

Earnings Data

Next earnings date for BIXT
Apr 22
2025
Most recent earnings per share
-$0.00
Missed by $0.00
(Oct 29/2024)
Consensus Estimate
--
(Oct 29/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BIXT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/29/2024 Q3 -- -- -$0.00 -- --
08/14/2024 Q2 -- -- -$0.00 -- --
04/22/2024 Q1 -- -- -$0.00 -- --
12/31/2023 Q4 -- -- -- -- --
11/03/2023 Q3 -- -- -$0.01 -- --
06/30/2023 Q2 -- -- -$0.01 -- --
03/31/2023 Q1 -- -- -$0.01 -- --
12/31/2022 Q4 -- -- -$0.01 -- --
09/30/2022 Q3 -- -- -$0.00 -- --
06/30/2022 Q2 -- -- -$0.01 -- --
03/31/2022 Q1 -- -- -$0.01 -- --
12/31/2021 Q4 -- -- -$0.01 -- --
09/30/2021 Q3 -- -- -$0.00 -- --
06/30/2021 Q2 -- -- -$0.01 -- --
03/31/2021 Q1 -- -- -$0.02 -- --
12/31/2020 Q4 -- -- -$0.01 -- --
09/30/2020 Q3 -- -- -$0.00 -- --
06/30/2020 Q2 -- -- -$0.01 -- --
03/31/2020 Q1 -- -- -$0.01 -- --
12/31/2019 Q4 -- -- -$0.01 -- --
09/30/2019 Q3 -- -- -$0.01 -- --
06/30/2019 Q2 -- -- -$0.00 -- --
03/31/2019 Q1 -- -- -$0.00 -- --
12/31/2018 Q4 -- -- -$0.00 -- --
09/30/2018 Q3 -- -- -$0.00 -- --
06/30/2018 Q2 -- -- -$0.00 -- --
03/31/2018 Q1 -- -- -$0.00 -- --
12/31/2017 Q4 -- -- -$0.00 -- --
09/30/2017 Q3 -- $112K $0.05 -- --
06/30/2017 Q2 -- $39.5K -$0.30 -- --
03/31/2017 Q1 -- $7.4K -$0.90 -- --
12/31/2016 Q4 -- $58.2K -- -- --
09/30/2016 Q3 -- $101.1K -$0.30 -- --
06/30/2016 Q2 -- $55.6K -$0.30 -- --
03/31/2016 Q1 -- $31.5K -$0.60 -- --
12/31/2015 Q4 -- -$2.1M -- -- --
09/30/2015 Q3 -- $110.8K -$0.07 -- --
06/30/2015 Q2 -- $59.4K -$6.00 -- --
03/31/2015 Q1 -- $62.5K -$0.30 -- --

Bioxytran Earnings Questions

  • How Much did Bioxytran Generate in Revenue Last Quarter?

    Bioxytran reported -- worth of top line sales in its most recent quarter.

  • Did Bioxytran Beat Earnings Last Quarter?

    Bioxytran announced earnings per share of -$0.00 which represents a miss of analyst forecast a -- per share.

  • Is Bioxytran Profitable?

    Bioxytran reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Bioxytran EPS Next Year?

    Bioxytran's earnings are forecast to grow from -$0.03 per share to -- per share next year representing an increase of --.

  • When is Bioxytran's Earnings Date?

    Bioxytran's next earnings date is April 22, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock